164 related articles for article (PubMed ID: 32945923)
1. The role of percutaneous CT-guided biopsy of an adrenal lesion in patients with known or suspected lung cancer.
McDermott E; Kilcoyne A; O'Shea A; Cahalane AM; McDermott S
Abdom Radiol (NY); 2021 Mar; 46(3):1171-1178. PubMed ID: 32945923
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of benign percutaneous adrenal biopsies in oncology patients.
Harisinghani MG; Maher MM; Hahn PF; Gervais DA; Jhaveri K; Varghese J; Mueller PR
Clin Radiol; 2002 Oct; 57(10):898-901. PubMed ID: 12413913
[TBL] [Abstract][Full Text] [Related]
3. Clinical indications, safety, and effectiveness of percutaneous image-guided adrenal mass biopsy: an 8-year retrospective analysis in 160 patients.
Schenker MP; Silverman SG; Mayo-Smith WW; Khorasani R; Glazer DI
Abdom Radiol (NY); 2024 Apr; 49(4):1231-1240. PubMed ID: 38430264
[TBL] [Abstract][Full Text] [Related]
4. (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients.
Sung YM; Lee KS; Kim BT; Choi JY; Chung MJ; Shim YM; Yi CA; Kim TS
Korean J Radiol; 2008; 9(1):19-28. PubMed ID: 18253072
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.
Toffart AC; Asfari S; Mc Leer A; Reymond E; Jankowski A; Moro-Sibilot D; Stephanov O; Ghelfi J; Lantuejoul S; Ferretti GR
Lung Cancer; 2020 Feb; 140():93-98. PubMed ID: 31901769
[TBL] [Abstract][Full Text] [Related]
6. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
8. CT-guided percutaneous core biopsy for assessment of morphologically normal adrenal glands showing high FDG uptake in patients with lung cancer.
Chassagnon G; Bennani S; Freche G; Magdeleinat P; Mansuet-Lupo A; Revel MP
Br J Radiol; 2018 Dec; 91(1092):20180090. PubMed ID: 29906237
[TBL] [Abstract][Full Text] [Related]
9. Metastases or benign adrenal lesions in patients with histopathological verification of lung cancer: Can CT texture analysis distinguish?
Andersen MB; Bodtger U; Andersen IR; Thorup KS; Ganeshan B; Rasmussen F
Eur J Radiol; 2021 May; 138():109664. PubMed ID: 33798933
[TBL] [Abstract][Full Text] [Related]
10. Adrenal Mass Biopsy in Patients Without Extraadrenal Primary Malignancy: A Multicenter Study.
Krishna S; Moloney BM; Bao B; Samji K; Williams AJ; Lim CS; Alabousi A; Mironov O; Russell J; Chang SD; Alrasheed S; Frank R; Schieda N
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329826. PubMed ID: 37877600
[No Abstract] [Full Text] [Related]
11. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
12. CT-guided core needle biopsy of the lung in patients with primary malignancy suspected of lung metastasis: 5-year experience from a single institution.
Zhu J; Wang X; Qu Y; Wen Z
Diagn Interv Radiol; 2021 Jul; 27(4):534-541. PubMed ID: 34313240
[TBL] [Abstract][Full Text] [Related]
13. Non-Diagnostic CT-Guided Percutaneous Needle Biopsy of the Lung: Predictive Factors and Final Diagnoses.
Tongbai T; McDermott S; Kiranantawat N; Muse VV; Wu CCC; Shepard JAO; Gilman MD
Korean J Radiol; 2019 Nov; 20(11):1515-1526. PubMed ID: 31606956
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous CT-guided cutting needle biopsy of pulmonary lesions: retrospective analysis of 153 procedures].
Besa C; Huele A; Bächler P; Cruz F
Rev Med Chil; 2013 Apr; 141(4):449-56. PubMed ID: 23900365
[TBL] [Abstract][Full Text] [Related]
15. Clinical role, safety and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation.
Kiranantawat N; McDermott S; Fintelmann FJ; Montesi SB; Price MC; Digumarthy SR; Sharma A
Respir Res; 2019 Jan; 20(1):23. PubMed ID: 30704502
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous CT-guided lung biopsy for the diagnosis of persistent pulmonary consolidation.
Brioulet J; David A; Sagan C; Cellerin L; Frampas E; Morla O
Diagn Interv Imaging; 2020 Nov; 101(11):727-732. PubMed ID: 32811758
[TBL] [Abstract][Full Text] [Related]
17. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
[TBL] [Abstract][Full Text] [Related]
18. C-arm cone-beam computed tomography with stereotactic needle guidance for percutaneous adrenal biopsy: initial experience.
Jiao D; Xie N; Wu G; Ren J; Han X
Acta Radiol; 2017 May; 58(5):617-624. PubMed ID: 27552980
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Yield of Computed Tomography-Guided Percutaneous Lung Biopsy in Patients With Prior Nondiagnostic Transbronchial Biopsy.
Li QK; Ding YK; Liu Y; Xia FF; Li L; Fu YF
J Comput Assist Tomogr; 2020; 44(2):305-309. PubMed ID: 32195810
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and accuracy of CT-guided percutaneous needle biopsy of cavitary pulmonary lesions.
Kiranantawat N; Petranović M; McDermott S; Gilman M; Digumarthy SR; Shepard JO; Sharma A
Diagn Interv Radiol; 2019 Nov; 25(6):435-441. PubMed ID: 31650972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
